Expanding Access to Low Cost Generic Drugs Act

Summary

Expanding Access to Low Cost Generic Drugs Act This bill amends the Federal Food, Drug, and Cosmetic Act to disqualify from receiving market exclusivity a generic drug manufacturer who enters into an agreement with the patent holder for a brand name drug to delay getting the generic drug approved or to delay marketing it.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 28 February 2018

   Introduced

   Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

   Source: IntroReferral

2. 28 February 2018

   Introduced

   Introduced in Senate

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in Senate · 28 February 2018 · Official file

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 28 February 2018

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 28 February 2018

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 28 February 2018

  Open at official source

Sponsors

• Tina Smith · D · Sponsor
• · sshr00 · Standing

Related records

• related to → Improving Access To Affordable Prescription Drugs Act
• related to → Improving Access To Affordable Prescription Drugs Act
• related to ← Affordable Medications Act